Moussy; Alain

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moussy; Alain.The latest application filed is for "novel oxazole derivatives that inhibit syk".

Company Profile

5.34.77

Moussy; Alain - Paris FR
MOUSSY; Alain - Dauphine FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds with anti-tumoral activity Grant 10,570,122 - Moussy , et al. Feb	2020-02-25
Oxazole derivatives that inhibit Syk Grant 10,392,373 - Moussy , et al. A	2019-08-27
Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors Grant 10,238,649 - Moussy , et al.	2019-03-26
Novel Oxazole Derivatives That Inhibit Syk App 20190055230 - Moussy; Alain ; et al.	2019-02-21
Benzimidazole derivatives as selective proteine kinase inhibitors Grant 10,202,370 - Moussy , et al. Feb	2019-02-12
Use Of Masitinib And Other Mast Cell Inhibitors For Treatment Of Parkinson's Disease App 20180311236 - MOUSSY; Alain ; et al.	2018-11-01
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation Grant 10,092,564 - Moussy , et al. October 9, 2	2018-10-09
Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors Grant 10,053,455 - Benjahad , et al. August 21, 2	2018-08-21
Treatment of mastocytosis with masitinib Grant 10,045,978 - Moussy , et al. August 14, 2	2018-08-14
Diazaspiroalkaneone-substituted Oxazole Derivatives As Spleen Tyrosine Kinase Inhibitors App 20180179195 - BENJAHAD; Abdellah ; et al.	2018-06-28
Use Of Masitinib For Treatment Of An Amyotrophic Lateral Sclerosis Patient Subpopulation App 20180117037 - MOUSSY; Alain ; et al.	2018-05-03
Compounds With Anti-tumoral Activity App 20180079747 - Moussy; Alain ; et al.	2018-03-22
Masitinib Combination For Use In Treating Breast Cancer App 20170340629 - MOUSSY; Alain ; et al.	2017-11-30
Use Of An Inhibitor Of Kinase Activity, Particularly Masitinib, For Treatment Of Prostate Cancer App 20170196853 - MOUSSY; Alain ; et al.	2017-07-13
Use Of Masitinib For The Treatment Of Progressive Supranuclear Palsy App 20170119760 - MOUSSY; Alain ; et al.	2017-05-04
Use Of Masitinib For The Treatment Of Crohn's Disease App 20170020867 - MOUSSY; Alain ; et al.	2017-01-26
Use Of Masitinib For Treatment Of Amyotrophic Lateral Sclerosis App 20160263110 - KINET; Jean Pierre ; et al.	2016-09-15
Method For Determining The Prognosis Of Pancreatic Cancer App 20160244845 - PIQUEMAL; David ; et al.	2016-08-25
Masitinib For Treating Gastric Cancer App 20160175302 - MOUSSY; Alain ; et al.	2016-06-23
Benzimidazole Derivatives As Selective Proteine Kinase Inhibitors App 20160152608 - MOUSSY; Alain ; et al.	2016-06-02
Masitinib For Treating Hepatic Cancer App 20160128999 - MOUSSY; Alain ; et al.	2016-05-12
Treatment Of Mastocytosis With Masitinib App 20160089368 - MOUSSY; Alain ; et al.	2016-03-31
Treatment Of Mastocytosis With Masitinib App 20160022671 - MOUSSY; Alain ; et al.	2016-01-28
Selective protein kinase inhibitors Grant 9,168,245 - Benjahad , et al. October 27, 2	2015-10-27
Use Of Small Molecule Inhibitors/activators In Combination With (deoxy)nucleoside Or (deoxy)nucleotide Analogs For Treatment Of Cancer And Hematological Malignancies Or Viral Infections App 20150290235 - Gros; Laurent ; et al.	2015-10-15
Use Of Masitinib For Treatment Of Cancer In Patient Subpopulations Identified Using Predictor Factors App 20150272945 - Moussy; Alain ; et al.	2015-10-01
Treatment of severe persistant asthma with masitinib Grant 9,078,894 - Moussy , et al. July 14, 2	2015-07-14
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors Grant 8,993,573 - Ciufolini , et al. March 31, 2	2015-03-31
Thiazole and oxazole kinase inhibitors Grant 8,962,665 - Moussy , et al. February 24, 2	2015-02-24
Aminothiazole compounds as kinase inhibitors and methods of using the same Grant 8,940,894 - Moussy , et al. January 27, 2	2015-01-27
Treatment of multiple sclerosis with masitinib Grant 8,906,357 - Moussy , et al. December 9, 2	2014-12-09
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors Grant 8,835,435 - Ciufolini , et al. September 16, 2	2014-09-16
Selective Protein Kinase Inhibitors App 20140179698 - Benjahad; Abdellah ; et al.	2014-06-26
Treatment Of Mastocytosis With Masitinib App 20140147415 - Moussy; Alain ; et al.	2014-05-29
2-(3-aminoaryl) Amino-4-aryl-thiazoles And Their Use As C-kit Inhibitiors App 20140088108 - CIUFOLINI; Marco ; et al.	2014-03-27
Substituted oxazole derivatives and their use as tyrosine kinase inhibitors Grant 8,658,659 - Grierson , et al. February 25, 2	2014-02-25
Treatment Of Multiple Myeloma With Masitinib App 20140051662 - Moussy; Alain ; et al.	2014-02-20
Treatment Of Service Persistant Asthma With Masitinib App 20140046063 - Moussy; Alain ; et al.	2014-02-13
Aminothiazole Compounds As Kinase Inhibitors And Methods Of Using The Same App 20130289045 - MOUSSY; Alain ; et al.	2013-10-31
Treatment Of Rheumatoid Arthritis With Masitinib App 20130267484 - Moussy; Alain ; et al.	2013-10-10
Treatment Of Multiple Sclerosis With Masitinib App 20130202555 - Moussy; Alain ; et al.	2013-08-08
Aminothiazole compounds as kinase inhibitors and methods of using the same Grant 8,492,545 - Moussy , et al. July 23, 2	2013-07-23
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors Grant 8,450,302 - Ciufolini , et al. May 28, 2	2013-05-28
Treatment Of Dementia Of Alzheimer's Type With Masitinib App 20130072474 - Kinet; Jean-Pierre ; et al.	2013-03-21
Thiazole And Oxazole Kinase Inhibitors App 20130035331 - Moussy; Alain ; et al.	2013-02-07
Combined Treatment Of Pancreatic Cancer With Gemcitabine And Masitinib App 20120309706 - Moussy; Alain ; et al.	2012-12-06
Treatment Of Gist With Masitinib App 20120302577 - Moussy; Alain ; et al.	2012-11-29
Process For The Synthesis Of 2-aminothiazole Compounds As Kinase Inhibitors App 20120196871 - MOUSSY; Alain ; et al.	2012-08-02
Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors Grant 8,227,470 - Moussy , et al. July 24, 2	2012-07-24
Substituted Oxazole Derivatives And Their Use As Tyrosine Kinase Inhibitors App 20120108616 - Grierson; David ; et al.	2012-05-03
Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors Grant 8,153,792 - Moussy , et al. April 10, 2	2012-04-10
2-(3-aminoaryl) Amino-4-aryl-thiazoles And Their Use As C-kit Inhibitors App 20120053186 - Ciufolini; Marco A. ; et al.	2012-03-01
2-aminoaryloxazole compounds as tyrosine kinase inhibitors Grant 8,110,591 - Moussy , et al. February 7, 2	2012-02-07
2-(3-aminoaryl) Amino-4-aryl-thiazoles And Their Use As C-kit Inhibitors App 20110201620 - Ciufolini; Marco ; et al.	2011-08-18
Use of tyrosine kinase inhibitors for treating inflammatory diseases Grant 7,741,335 - Moussy , et al. June 22, 2	2010-06-22
Potent, selective and non toxic c-kit inhibitors Grant 7,727,731 - Moussy , et al. June 1, 2	2010-06-01
2-aminoaryloxazole compounds as tyrosine kinase inhibitors Grant 7,718,676 - Moussy , et al. May 18, 2	2010-05-18
Process For The Synthesis Of 2-aminothiazole Compounds As Kinase Inhibitors App 20100121063 - Moussy; Alain ; et al.	2010-05-13
2-Aminoaryloxazole compounds as tyrosine kinase inhibitors App 20100113471 - Moussy; Alain ; et al.	2010-05-06
Use of tyrosine kinase inhibitors for treating allergic diseases Grant 7,700,610 - Moussy , et al. April 20, 2	2010-04-20
Combination Treatment Of Solid Cancers With Antimetabolites And Tyrosine Kinase Inhibitors App 20100093750 - Moussy; Alain ; et al.	2010-04-15
Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD) Grant 7,678,805 - Moussy , et al. March 16, 2	2010-03-16
Use of tyrosine kinase inhibitors for treating CNS disorders App 20090082360 - MOUSSY; Alain ; et al.	2009-03-26
2-(3-aminoaryl) Amino-4-aryl-thiazoles And Their Use As C-kit Inhibitors App 20080255141 - Ciufolini; Marco ; et al.	2008-10-16
Substituted Oxazole Derivatives and their Use as Tyrosine Kinase Inhibitors App 20080242704 - Grierson; David ; et al.	2008-10-02
2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases Grant 7,423,055 - Ciufolini , et al. September 9, 2	2008-09-09
Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple Myeloma App 20080207572 - Moussy; Alain ; et al.	2008-08-28
Use Of C-Kit Inhibitors For Treating Inflammatory Muscle Disorders Including Myositis And Muscular Dystrophy App 20080146585 - Moussy; Alain ; et al.	2008-06-19
2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors App 20080039466 - Moussy; Alain ; et al.	2008-02-14
Tailored Treatment Suitable for Different Forms of Mastocytosis App 20080025916 - Kinet; Jean-Pierre ; et al.	2008-01-31
Use of C-Kit Inhibitors for Treating Plasmodium Related Diseases App 20080004279 - Moussy; Alain ; et al.	2008-01-03
Use of Mast Cells Inhibitors for Treating Patients Exposed to Chemical or Biological Weapons App 20070249628 - Moussy; Alain ; et al.	2007-10-25
Use of C-Kit Inhibitors for Treating Fibrosis App 20070225293 - Moussy; Alain ; et al.	2007-09-27
Use of tyrosine kinase inhibitors for treating cerebral ischemia App 20070191267 - Kinet; Jean-Pierre ; et al.	2007-08-16
2-Aminoaryloxazole compounds as tyrosine kinase inhibitors App 20070142390 - Moussy; Alain ; et al.	2007-06-21
Use of c-kit inhibitors for treating type II diabetes App 20070032521 - Moussy; Alain ; et al.	2007-02-08
Use of tyrosine inhibitors for whitening human skin and treating melanocyted dysfunction associated diseases App 20060204459 - Moussy; Alain ; et al.	2006-09-14
Potent, selective and non toxic c-kit inhibitors App 20060166281 - Moussy; Alain ; et al.	2006-07-27
2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors App 20050239852 - Ciufolini, Marco ; et al.	2005-10-27
Use of tyrosine kinase inhibitors for treating cns disorders App 20050222091 - Moussy, Alain ; et al.	2005-10-06
Use of tyrosine kinase inhibitors for treating substance use disorders App 20050203098 - Moussy, Alain ; et al.	2005-09-15
Use of tyrosine kinase inhibitors for treating autoimmune diseases App 20050176687 - Moussy, Alain ; et al.	2005-08-11
Method for identifying compounds that specifically deplete mast cells App 20050089838 - Moussy, Alain ; et al.	2005-04-28
Use of tyrosine kinase inhibitors for treating inflammatory diseases App 20050059688 - Moussy, Alain ; et al.	2005-03-17
Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis App 20050054617 - Moussy, Alain ; et al.	2005-03-10
Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) App 20040266801 - Moussy, Alain ; et al.	2004-12-30
Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensis App 20040266797 - Moussy, Alain ; et al.	2004-12-30
Use of tyrosine kinase inhibitors for treating bone loss App 20040266771 - Moussy, Alain ; et al.	2004-12-30
Use of tyrosine kinase inhibitions for treating allergic diseases App 20040259893 - Moussy, Alain ; et al.	2004-12-23
Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) App 20040259892 - Moussy, Alain ; et al.	2004-12-23
Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections App 20040241226 - Moussy, Alain ; et al.	2004-12-02
Use of tyrosine kinase inhibitors for promoting hair growth App 20040242612 - Moussy, Alain ; et al.	2004-12-02
Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis App 20040242601 - Moussy, Alain ; et al.	2004-12-02
2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases App 20040110810 - Ciufolini, Marco ; et al.	2004-06-10
Method for screening compounds capable of depleting mast cells App 20030091974 - Moussy, Alain ; et al.	2003-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.